• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 25 Nov

    AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020

    SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it experienced strong demand for its cancer… Read More..

    Share this:
  • 24 Nov

    ZACKS SCR IS BULLISH ON SOLIGENIX, SUGGESTING 580% UPSIDE; MULTIPLE ASSETS COMBINE TO SET UP THREE NEAR-TERM POTENTIAL CATALYSTS

    Soligenix (NASDAQ: SNGX) is earning Zacks SCR analysts’ confidence, who prescribe a 12-month price target of $15 per share. A rise in that magnitude represents a more than 580% increase from its current trading price*. Several reasons combine to justify the lofty valuation. (*share price and percentage calculation as of… Read More..

    Share this:
  • 24 Nov

    Harbor Custom Development, Inc. Projects $47 Million in 2020 Revenue and $70 Million in 2021

    Gig Harbor, Washington , Nov. 23, 2020 (GLOBE NEWSWIRE) -- Harbor Custom Development, Inc. (“Harbor,” “Harbor Custom Homes®,” or the “Company”), (NASDAQ:HCDI), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced that its 2020 gross revenues are projected to be… Read More..

    Share this:
« Previous 1 … 131 132 133 134 135 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact